Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Allergic Reactions

Allergic Reactions

Allergic Drug Reactions

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...

Inhaled Medications

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Targeting the neutrophil-DPP-1-protease axis in airway disease: current evidence and future indications.

Respiratory medicine·2026

Same author

Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden-A SANI Multicenter Cohort.

Journal of personalized medicine·2026

Same author

Toward international collaboration in allergy care - WAO White Book on Allergy 2026 - Introduction.

The World Allergy Organization journal·2026

Same author

The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities.

The World Allergy Organization journal·2026

Same author

Toward equitable and evidence-based care in Hereditary Angioedema: Time for inclusive global guidelines.

The World Allergy Organization journal·2026

Same author

Immunostimulant-induced maturation of monocyte-derived dendritic cells in respiratory infection prophylaxis.

Drugs in context·2026

Search research articles

Related Experiment Video

Updated: Dec 6, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Medical devices in allergy practice.

Todor A Popov¹, Gianni Passalacqua², Sandra N González-Díaz³

¹University Hospital Sv. Ivan Rilski, Sofia, Bulgaria.

The World Allergy Organization Journal

|October 7, 2020

Summary

This summary is machine-generated.

This paper details medical devices for allergy diagnosis and treatment. It categorizes devices for allergology, aiding integrated patient care pathways.

Keywords:

AAP, Asthma Action Plan ATS, American Thoracic Society Airway inflammation Allergic rhinitis Allergology Allergy Allergy diagnosis Asthma CE mark, Conformité Européenne mark CO, Carbon monoxide DPIs, Dry Powder Inhalers EAI/AAI, Epinephrine/Adrenaline Auto-Injector EBC, Exhaled Breath Condensate EBT, Exhaled Breath Temperature EDS, Exhalation Delivery Systems EMA, European Medicines Agency ERS, European Respiratory Society ERV, Expiratory Reserve Volume FDA, Food and Drug Administration FEF, Forced Expiratory Flows FEV1, Forced Expiratory Volume in 1 second FOT, Forced Oscillation Technique FRC, Functional Residual Capacity FVC, Forced Vital Capacity FeNO, Fractional Exhaled Nitric Oxide GLI, Global Lung Function Initiative IOS, Impulse Oscillometry IRV, Inspiratory Reserve Volume Lung function tests MDPS, Metered-Dose Pump Sprays Medical devices NDDD, Nasal Drug Delivery Device NO, Nitric oxide PDMI, Pressurized Metered Dose Inhaler PEF, Peak Expiratory Flow PNIF, Peak Nasal Inspiratory Flow PT, Patch Tests PhPT, Photopatch tests Ppb, part per billion RV, Residual Volume SPT, Skin Prick Test Skin tests TLC, Total Lung Capacity UV, Ultra Violet VC, Vital Capacity VT, Tidal Volume WAO, World Allergy Organization WHO, World Health Organization m-health

More Related Videos

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

Murine Model of Allergen Induced Asthma

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

Related Experiment Videos

Last Updated: Dec 6, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

Murine Model of Allergen Induced Asthma

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

Area of Science:

Allergy and immunology
Medical device technology

Background:

Medical devices are crucial for disease diagnosis, prevention, treatment, and monitoring.
Allergology, an interdisciplinary field, recognizes allergic reactions as systemic with diverse organ-specific manifestations.
Existing literature lacks a comprehensive overview of medical devices specifically for allergology.

Purpose of the Study:

To provide the first structured overview of medical devices used in allergology.
To categorize these devices into general and organ-specific types.
To support the integration of care pathways for patients with allergic comorbidities.

Main Methods:

A position paper by the World Allergy Organization (WAO).
Systematic review and categorization of medical devices relevant to allergology.
Analysis of devices for both routine and advanced diagnostic and management purposes.

Main Results:

Medical devices in allergology are classified as general or organ-specific.
General devices support core allergology principles, while organ-specific devices are shared with other specialties.
The paper includes devices for daily practice, sophisticated diagnostics, and modern disease management.

Conclusions:

This WAO position paper offers a structured framework for understanding medical devices in allergology.
It emphasizes the role of these devices in enhancing diagnostic accuracy and treatment efficacy.
The document aims to facilitate integrated care for patients with allergic conditions and comorbidities.